Moxifloxacin Hydrochloride

CAS 186826-86-8 28 current records 5 historicalSmall Molecule

Who holds supplier records for Moxifloxacin Hydrochloride? 28 organisations hold a current record for Moxifloxacin Hydrochloride: an active US FDA Type II Drug Master File or a CEP. A further 5 organisations have only historical (inactive) DMF filings. 19 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (15), China (6), Italy (1) and Germany (1); not recorded for 5.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Moxifloxacin Hydrochloride: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/moxifloxacin-hydrochloride

Reading the evidence

  • 28 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    15 of the 23 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (28)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Moxifloxacin Hydrochloride. Country is the organisation's recorded country, not necessarily the manufacturing site.

India15China6Italy1Germany1Country not recorded for 5
Need Moxifloxacin Hydrochloride sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (19)

Certificates of Suitability on the EDQM register for Moxifloxacin Hydrochloride, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 27 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
NEWLAND PHARMACEUTICAL CO. LTD. ChanggeCN
CEP 2025-273 - Rev 00
Moxifloxacin hydrochloride
Sept 2026—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2024-302 - Rev 01
Moxifloxacin hydrochloride, Process-II
Jun 2026—
HEC PHARM GMBH BerlinDE
CEP 2013-225 - Rev 04
Moxifloxacin hydrochloride
Mar 2026—
MSN PHARMACHEM PRIVATE LIMITED SangareddyIN
CEP 2007-355 - Rev 06
Moxifloxacin hydrochloride, Monohydrate, micronised and non-micronised
Feb 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2013-201 - Rev 04
Moxifloxacin hydrochloride
Sept 2025—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2015-269 - Rev 03
Moxifloxacin hydrochloride, Monohydrate
Aug 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2013-078 - Rev 02
Moxifloxacin hydrochloride, Process II
Aug 2025—
ENALTEC LABS PRIVATE LIMITED Navi MumbaiIN
CEP 2022-487 - Rev 00
Moxifloxacin hydrochloride
Apr 2025—
HETERO DRUGS LIMITED HyderabadIN
CEP 2017-113 - Rev 02
Moxifloxacin hydrochloride
Mar 2025—
CHONGQING HUAPONT PHARMACEUTICAL CO., LTD. ChongqingCN
CEP 2021-458 - Rev 00
Moxifloxacin hydrochloride
Feb 2025—
HEC API YICHANG CO., LTD. Yidu CityCN
CEP 2021-396 - Rev 01
Moxifloxacin hydrochloride, Site 3
Sept 2024—
BAYER AG LeverkusenDE
CEP 2008-067 - Rev 03
Moxifloxacin hydrochloride
Jun 2024—
MICRO LABS LIMITED BengaluruIN
CEP 2022-023 - Rev 00
Moxifloxacin hydrochloride
May 2024—
ZHEJIANG NHU COMPANY LTD. Shaoxing CityCN
CEP 2021-411 - Rev 00
Moxifloxacin hydrochloride
Nov 2023—
ARAGEN LIFE SCIENCES LIMITED HyderabadIN
CEP 2014-101 - Rev 02
Moxifloxacin hydrochloride, Monohydrate
Nov 2023—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2016-327 - Rev 04
Moxifloxacin hydrochloride
Oct 2023—
ZHEJIANG GUOBANG PHARMACEUTICAL CO., LTD. ShangyuCN
R0-CEP 2020-316 - Rev 01
Moxifloxacin hydrochloride
Aug 2023—
INNOVARE LABS PRIVATE LIMITED VisakhapatnamIN
R0-CEP 2020-334 - Rev 00
Moxifloxacin hydrochloride
Dec 2022—
NOSCH LABS PRIVATE LIMITED HyderabadIN
R1-CEP 2015-316 - Rev 00
Moxifloxacin hydrochloride
Jul 2022—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (5)

Organisations whose Type II DMFs for Moxifloxacin Hydrochloride are no longer active. These show a past filing, not current supply.

Show all 5 historical records
  • HISUN PHARMACEUTICAL NANTONG CO LTD
    Inactive DMF 28597 · filed Oct 2014
  • ALP PHARM BEIJING CO LTD
    Inactive DMF 25368 · filed Aug 2011
  • Brazil · Inactive DMF 23315 · filed Nov 2009
  • India · Inactive DMF 20170 · filed Jul 2008
  • MYLAN LABORATORIES LTD
    Inactive DMF 17000 · filed Dec 2003

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Moxifloxacin Hydrochloride is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200735).

Chemical identity

IUPAC name
7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid;hydrochloride
Canonical SMILES
COC1=C2C(=CC(=C1N3C[C@@H]4CCCN[C@@H]4C3)F)C(=O)C(=CN2C5CC5)C(=O)O.Cl
InChIKey
IDIIJJHBXUESQI-DFIJPDEKSA-N
Synonyms
AL-15469A, Avelox, BAY 12-8039, BAY-12-8039, Minims, Moxeza, Moxifloxacin (as hydrochloride), Moxifloxacin hcl, Moxifloxacin hydrochloride, Moxivig, NSC-758875, Vigamox

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Fluoroquinolone Antibacterial; Quinolone Antimicrobial
Chemical structure
Fluoroquinolones; Quinolones

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Moxifloxacin Hydrochloride?

28 organisations hold an active US FDA Type II Drug Master File or a CEP for Moxifloxacin Hydrochloride: Hetero Drugs Limited (India), MSN PHARMACHEM PRIVATE LTD (India), SHANKUS PHARMA PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), CHONGQING HUAPONT PHARMACEUTICAL CO LTD, CHROMO LABORATORIES INDIA PRIVATE LTD (India), Dr. Reddy's Laboratories Ltd. (India) and INNOVARE LABS PRIVATE LTD (India), and 20 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Moxifloxacin Hydrochloride Drug Master Files are active?

Hetero Drugs Limited (DMF 26525, 26074), MSN PHARMACHEM PRIVATE LTD (DMF 20755, 24003), SHANKUS PHARMA PRIVATE LTD (DMF 42533, 42536), APITORIA PHARMA PRIVATE LTD (DMF 24371), CHONGQING HUAPONT PHARMACEUTICAL CO LTD (DMF 37038, 28551), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 31720), Dr. Reddy's Laboratories Ltd. (DMF 16999) and INNOVARE LABS PRIVATE LTD (DMF 35271) and 11 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Moxifloxacin Hydrochloride records mean?

5 organisations have only inactive Type II DMFs for Moxifloxacin Hydrochloride. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Moxifloxacin Hydrochloride have a European Certificate of Suitability?

Yes. 19 organisations hold a valid CEP for Moxifloxacin Hydrochloride on the EDQM register, including NEWLAND PHARMACEUTICAL CO. LTD. Changge (CN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN), HEC PHARM GMBH Berlin (DE), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN) and MACLEODS PHARMACEUTICALS LIMITED Mumbai (IN) and 13 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Moxifloxacin Hydrochloride supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Moxifloxacin Hydrochloride?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.